Otrivin Gyermek (Xylometazoline Hydrochloride)

Otrivin Gyermek contains xylometazoline, an alpha‑2‑adrenergic agonist that acts on the nasal mucosal vasculature to reduce congestion.

• Common cold in children: temporary relief of nasal blockage caused by viral upper respiratory infection.
• Allergic rhinitis in children: reduction of swelling and congestion due to seasonal allergens.
• Sinusitis in children: helps ease nasal airflow by decongesting inflamed nasal passages.
• Post‑operative nasal care: supports clearance of nasal passages after ENT procedures.

• Xylometazoline hydrochloride selectively stimulates alpha‑2 adrenergic receptors on the smooth muscle of nasal blood vessels. This activation causes vasoconstriction, which reduces blood flow to the nasal mucosa, decreasing edema and opening the airway for improved breathing.

Adverse reactions to Otrivin Gyermek are generally mild and reversible.

Common Side Effects

• Burning or stinging sensation in the nose.
• Nasal dryness or irritation.
• Sneezing shortly after application.
• Mild headache.
• Transient taste disturbance.

Serious or Rare Side Effects

• Persistent nasal irritation or ulceration.
• Severe nosebleeds (epistaxis).
• Allergic reactions such as rash, itching or swelling.
• Hypertension exacerbation in susceptible individuals.
• Rebound congestion with prolonged use beyond recommended duration.

Before using Otrivin Gyermek, consider the following safety measures:

• Age restriction: not for children under 2 years without medical advice.
• Duration limit: limit use to 3‑5 days to avoid rebound congestion.
• Pre‑existing conditions: use cautiously in patients with hypertension, heart disease, diabetes mellitus, or thyroid disorders.
• Concomitant nasal medications: avoid using other topical decongestants simultaneously.
• Pregnancy and lactation: consult a healthcare professional before use.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other medicines that affect vascular tone or blood pressure. Major Interactions (Avoid):\n- Monoamine oxidase inhibitors (MAOIs): risk of excessive vasoconstriction.

• Systemic sympathomimetics (e.g., pseudoephedrine): additive hypertensive effect.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents: may reduce efficacy of blood‑pressure control.
• Other intranasal decongestants: increased risk of local irritation and rebound congestion.
• Topical corticosteroids: monitor for enhanced mucosal dryness.
• Herbal supplements containing ephedra: potential additive sympathomimetic action.